• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Disruption in Healthcare: Amazon, Brexit, Trump, MACRA, Gig Workers, Aging – 27 Factors That Could Change the Business

$2,995.00 – $5,990.00

Clear
SKU: KLI15634024 Categories: Healthcare Facilities & Settings, Healthcare Information Technology, Healthcare Market Research Pages: 98
  • Description
  • Table of Contents
  • Latest reports

Description

 

In healthcare, there are 27 potential disruptors that could have a large impact on the market.  This report discusses them and how they will impact markets in healthcare and pharmaceuticals:
• New US Healthcare Policies/ACA Status
• Reimbursement Changes in Europe and Other Developed Nations
• Brexit
• Emerging Countries
• Demographic Changes
• Ransomware and Blockchain Strategies
• Telemedicine
• Walk-in Clinics
• MACRA
• Empowered Consumers
• “Gig” Economy
• Value-Based Reimbursement
• Brazilian Biotech Market
• Healthcare in China
• Association Healthcare Plans
• Brazil as a Significant Pharma Player
• Technology Advances
• Physician Shortages, Advanced Nurse Surplus
• Changes in Drug Sourcing
• Mergers and Acquisitions
• IPO and Venture Investment
• And Others…
This report details current challenges and upending factors in healthcare markets globally. It also processes these developments into useful market forecasts in overall healthcare and pharmaceuticals specifically, in 18 ten-year forecast tables.
From the report:
Empowered Healthcare Consumers – The Internet has dramatically increased the availability of medical, health and wellness information for consumers in virtually all world markets. As of early 2018, almost 4 billion people used the Internet, representing over 52% of the world’s population. Usage is highest in North America and Europe, with about 90% and 80% of the population online, respectively. While just 32% of Africa is online and about 48% of Asia, these proportions are expected to increase strongly over the next several years. As a result, consumers are easily able to access:
• health and wellness information in online publications, platforms and communities;
• provider (physician, hospital, lab, insurance) websites and information.
As a result, patients are becoming better educated and informed. By learning about the availability of healthcare products and services in other areas and connecting with other providers, they are also increasing competition in the marketplace.
MACRA and Value Based Reimbursement – Also known as Quality-Based Reimbursement, VBR is a means to compensate care providers in a way that ties payments to the quality of care provided while rewarding providers for efficiency and effectiveness. It is an alternative to fee-for-service (FFS) reimbursement which pays providers for services delivered based on bill charges or annual fee schedules.
The “Gig Economy” is a relatively new term that refers to the growing shift away from fulltime employment towards part time, temporary and/or project work as a means to earn income. These two forms of professional activity are structured quite differently although both forms may be utilized to perform similar functions – ie. some workers in a particular company or profession may be characterized as fulltime, while others may be legally characterized as temporary or project workers.
Increasing and Aging Populations –    Over the past 50 years, the world’s population has expanded significantly and over the next decade, this growth is expected to continue. The total population expanded by 1.14% per year from 6.8 billion in 2008 to more than 7.6 billion in 2018 and is expected to exceed 8.5 billion by 2028. Greatest growth will occur in Africa at an estimated 2.55% per year, followed by Oceana at 1.43% per year and Asia at 0.94% annually.
Trump Administration Positions and New Policies -In December 2017, President Trump signed a bill repealing the Individual Mandate of the ACA beginning in 2019. The mandate is a core component of the Affordable Care Act and fines people who do not have health insurance. For tax year 2017, this fine is either 2.5% of the individual’s total household income, or $695 per uninsured adult and $347.50 per uninsured child (up to a maximum of $2,085), whichever figure is higher. But the tax bill leaves every other major component of the ACA intact.
Kalorama Analysis: Processing the 27 Factors into Market Forecasts
Kalorama Information’s Unique report takes a look at these factors and how they could impact pharmaceutical and healthcare markets.  The report includes the following forecasts:
• Global Healthcare Market, 2017-2027 -Worst Case/Best Case/Most Like Case Scenario
• U.S. Healthcare Market, 2017-2027 -Worst Case/Best Case/Most Like Case Scenario
• Europe Healthcare Market, 2017-2027 -Worst Case/Best Case/Most Like Case Scenario
• Global Pharmaceutical Market, 2017-2027 -Worst Case/Best Case/Most Like Case Scenario
• U.S. Pharmaceutical Market, 2017-2027 -Worst Case/Best Case/Most Like Case Scenario
• Europe Pharmaceutical Market, 2017-2027 -Worst Case/Best Case/Most Like Case Scenario
FIND OUT MORE: https://www.kaloramainformation.com/Era-Uncertainty-Healthcare-Factors-Disrupt-11538729/

 

Table of Contents

CHAPTER 1: EXECUTIVE SUMMARYTHE GLOBAL HEALTHCARE INDUSTRY

SCOPE AND METHODOLOGY

CHAPTER 2: OVERVIEWINTRODUCTION

FACTOR ONE: GLOBAL DEMOGRAPHIC SHIFTS

Global Population Growth and Aging

Exhibit 2-1: Total Global Population by Region, 2008 – 2028, in Millions
Exhibit 2-2: Global Population of People Age 60 and Older by Region, 2008 – 2028, in Millions

Obesity

FACTOR TWO: THE GIG ECONOMY

Exhibit 2-3: Key Characteristics of Employment vs. Gig Workers, 2018
Exhibit 2-4: Risks and Rewards of Employment vs. Gig Work, 2018

GLOBAL HEALTHCARE TRENDS
FACTOR THREE: RISING RATES OF DISEASE DIAGNOSIS AND TREATMENT

FACTOR FOUR: GROWING U.S. OUT OF POCKET SPENDING ON HEALTHCARE

FACTOR FIVE: ALTERNATIVE THERAPIES AND ENERGY MEDICINE

FACTOR SIX: HEALTHCARE IPO BOOM

Exhibit 2-5: Total and Healthcare Global IPO Deal Volume, 2012 – 2017
Exhibit 2-6: Total and Healthcare Global IPO Deal Value, 2012 – 2017, In $Billions

FACTOR SEVEN: MERGERS AND ACQUISITIONS

Exhibit 2-7: Total U.S. Healthcare M&A Deal Value, 2009 – 2017, in $Billions
Exhibit 2-8: Selected Recent Healthcare M&A Activity

Product Launches
FACTOR EIGHT: BITCOIN AND BLOCKCHAIN

FACTOR NINE: AMAZON AND THE NEW HEALTHCARE BEHEMOTHS
FACTOR TEN: THREATS OF WAR

CHAPTER 3: KEY ISSUES: U.S.
INTRODUCTION
FACTOR ELEVEN: AFFORDABLE CARE ACT CHANGES/INDIVIDUAL MANDATE REPEAL
Individual Mandate Repeal
FACTOR TWELVE: ASSOCIATION HEALTHCARE PLANS
Total Repeal
Further Changes to the ACA
FACTOR THIRTEEN: MACRA, PAMA AND REIMBURSEMENT CHANGES
MACRA and Value Based Reimbursement
FACTOR FOURTEEN – REMOTE PATIENT MONITORING AND TELEHEALTH
FACTOR FIFTEEN: HOSPITAL PRODUCTION OF GENERIC MEDICINES
FACTOR SIXTEEN: LEGALIZATION OF MARIJUANA

Exhibit 3-1: Current and Recently-Approved State Laws Legalizing Marijuana for Medical or Recreational Purposes, Q1 2018
Exhibit 3-2: Federal Penalties for Marijuana Possession, Sale, Cultivation & Paraphernalia, 2018

FACTOR SEVENTEEN 2017 TAX REFORM LEGISLATION CONSEQUENCES
FACTOR EIGHTEEN: PHYSICIAN SHORTAGE, NP SURPLUS
Physician Shortage
Advanced Practice Nurse Surplus
Older Workers
FACTOR NINETEEN: URGENT CARE AND RETAIL CLINICS
Urgent Care Centers
Retail Clinics
Other Healthcare Venues
FACTOR TWENTY: U.S. OPIOID CRISIS
FACTOR TWENTY-ONE: RANSOMWARE AND CYBERCRIME

CHAPTER 4: KEY ISSUES: EUROPE
INTRODUCTION

Exhibit 4-1: Key Indicators: Western Europe, Eastern Europe, Switzerland, Russia, 2017

Economic Rebound in the Eurozone
FACTOR TWENTY-TWO: BREXIT
FACTOR TWENTY-THREE: AUSTERITY
FACTOR TWENTY-FOUR: BAILOUT EU NATIONS: GREECE, IRELAND, PORTUGAL, SPAIN, CYPRESS
Technology Laggership in Europe
High Costs of Doing Business
CHAPTER 5: KEY ISSUES: EMERGING MARKETS
INTRODUCTION

Exhibit 5-1: Characteristics of Tier I, II and III Players, 2017

FACTOR TWENTY FIVE: DEVELOPED NATIONS TURN TO BIOTECH

Exhibit 5-2: Key Indicators: Tier I Countries, 2017

Growing Pharma and Biotech Industries
FACTOR TWENTY-SIX: RISE OF EASTERN EUROPE
China and India

Exhibit 5-3: Key Indicators: Tier II Countries, 2017

Changing Disease Patterns
FACTOR TWENTY-SEVEN: CHINA/INDIA HEALTHCARE REFORM, BRAZIL PHARMA REFORM

Exhibit 5-4: Key Healthcare Reforms and Remaining Current Gaps in China and India, 1997 – 2017

Intellectual Property Struggles
Corporate Incentives
China and India Focus on Biotech
Shift from Generics to Innovative Products
Outsourcing Boom
Tier III Countries
Brazil Pharma’s Boom
Political and Economic Instability
CHAPTER 6: HEALTHCARE MARKET FORECASTS CONSIDERING THE 28 FACTORS – BEST CASE, MODERATE CASE, WORST CASE
OVERVIEW
TOTAL HEALTHCARE MARKET FORECASTS

Exhibit 6-1: Total Global Healthcare Market in $ Billions, Historic, Best Case, Most Likely & Worst Case, 2007 – 2027, in $Billions
Exhibit 6-2: Total Global Healthcare Market Growth for Best Case, Most Likely & Worst Case, 2017 – 2027, in $Billions

U.S. Healthcare Market

Exhibit 6-3: Total U.S. Healthcare Market, Best Case, Most Likely & Worst Case, 2007 – 2027 ($BN)
Exhibit 6-4: Total Global Healthcare Market Growth for Best Case, Most Likely & Worst Case, 2017 – 2027, in $Billions

Europe Healthcare Market

Exhibit 6-5: Total European Healthcare Market: Best Case, Most Likely & Worst Case, 2007 – 2027 ($BN)
Exhibit 6-6: Total European Healthcare Market Growth for Best Case, Most Likely & Worst Case, 2017 – 2027, in $Billions

Asia Healthcare Market

Exhibit 6-7: Total Asian Healthcare Market: Best Case, Most Likely & Worst Case, 2007 – 2027($BN)
Exhibit 6-8: Total Asian Healthcare Market Growth for Best Case, Most Likely & Worst Case, 2017 – 2027, in $Billions

TOTAL PHARMACEUTICAL MARKET FORECASTS

Exhibit 6-9: Total Global Pharmaceutical Market: Best Case, Most Likely & Worst Case, 2007 – 2027 ($BN)
Exhibit 6-10: Total Global Pharmaceutical Market: Best Case, Most Likely & Worst Case, 2017 – 2027, in $Billions

U.S. Pharmaceutical Market

Exhibit 6-11: U.S. Pharmaceutical Market: Best Case, Most Likely & Worst Case, 2007 – 2027 ($BN)
Exhibit 6-12: Total U.S. Pharmaceutical Market Growth for Best Case, Most Likely & Worst Case, 2017 – 2027, in $Billions

Europe Pharmaceutical Market

Exhibit 6-13: European Pharmaceutical Market: Best Case, Most Likely & Worst Case, 2007 – 2027 ($BN)
Exhibit 6-14: Total European Pharmaceutical Market Growth for Best Case, Most Likely & Worst Case, 2017 – 2027, in $Billions

Asia Pharmaceutical Market

Exhibit 6-15: Asian Pharmaceutical Market: Best Case, Most Likely & Worst Case, 2007 – 2027 ($BN)
Exhibit 6-16: Total Asian Pharmaceutical Market Growth for Best Case, Most Likely & Worst Case, 2017 – 2027, in $Billions
    Clinical Diagnostics MasterFile
    August 30, 2021
    The U.S. Market for Urgent Care Centers (Including COVID-19, POC Tests, Vaccines and Other Sales)
    September 18, 2020
    The Market for Urgent Care Centers
    August 6, 2019
    Retail Clinics 2019 Forecast: Locations, Revenues, Supplier Sales, Trends, Consumer Survey
    November 15, 2018

Related products

  • Placeholder image

    Healthcare in a Recession (OTC, Generics, Out of Pocket Spending, Healthcare Legislation, Retail Clinics, Outsourcing and Other Topics)

    $500.00 – $3,990.00
  • Placeholder image

    Retail Clinics and the In-Store Healthcare Market 2009: Bright Spot in the Current Economy?

    $1,995.00 – $7,000.00
  • Placeholder image

    Wellness Market Opportunities in the Aging American Population: Alternative Medicine Markets for Age-Related Health Issues

    $3,500.00 – $7,000.00
  • Placeholder image

    U.S. Markets for EMR (Electronic Medical Record) Technology

    $995.00 – $7,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain  June 24, 2025
  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Point of Care (POC) Infectious Disease Diagnostic Testing MarketPoint of Care Diagnostics Market in Retail Clinics (Cholesterol, Diabetes, Influenza,...
Scroll to top